pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
elisrasib
elisrasib [INN]
Solid Tumor
D3 Bio Inc
0 catalysts
Phase 2
elraglusib
Neuroblastoma
Glycogen synthase kinase-3 beta
$ACTUACTUATE THERAPEUTICS, INC.
0 catalysts
Phase 2
eltivutabart
eltivutabart [INN]
Pancreatic Ductal Adenocarcinoma
Trishula Therapeutics Inc
0 catalysts
← prev
page 36 of 50
next →
131
Pain89
Neurology1
Phase 2
elunetirom
Bipolar I Disorder
Autobahn Therapeutics Inc
0 catalysts
Phase 2
elzovantinib
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
0 catalysts
Phase 2
emicizumab
Hemlibra (emicizumab-kxwh)
Acquired Hemophilia A
Coagulation factor IX and X
Chugai Pharmaceutical Co Ltd
0 catalysts
Phase 2
emodepside
Onchocerciasis (River Blindness)
Bayer AG
0 catalysts
Phase 2
emraclidine
Psychosis
$ABBVAbbVie Inc.
0 catalysts
Phase 2
emrusolmin
emrusolmin [INN]
Multiple System Atrophy (Multi-System Degeneration)
$TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
0 catalysts
Phase 2
emugrobart
emugrobart [INN]
Obesity
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
enamptcumab
eNamptor
Acute Respiratory Distress Syndrome
Aqualung Therapeutics Corp
0 catalysts
Phase 2
encoberminogene rezmadenovec
Refractory Angina
XyloCor Therapeutics Inc
0 catalysts
Phase 2
endoxifen
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$ATOSATOSSA THERAPEUTICS, INC.
0 catalysts
Phase 2
enekinragene inzadenovec
Osteoarthritis
$PCRXPacira BioSciences, Inc.
0 catalysts
Phase 2
engasertib
engasertib [INN]
Hereditary Hemorrhagic Telangiectasia (Osler–Weber–Rendu Disease)
Vaderis Therapeutics AG
0 catalysts
Phase 2
eniluracil
Metastatic Breast Cancer
Dihydropyrimidine dehydrogenase [NADP(+)]
$PCSAProcessa Pharmaceuticals, Inc.
0 catalysts
Phase 2
enobosarm
Obesity
Androgen receptor
$VERUVERU INC.
0 catalysts
Phase 2
enozertinib
enozertinib [INN]
Solid Tumor
$ORICOric Pharmaceuticals, Inc.
0 catalysts
Phase 2
enzomenib tartrate
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Sumitomo Pharma Co Ltd
0 catalysts
Phase 2
epaldeudomide
epaldeudomide [INN]
Systemic Lupus Erythematosus
Kangpu Biopharmaceuticals Ltd
0 catalysts
Phase 2
epeleuton
epeleuton [INN]
Sickle Cell Disease
Afimmune Biopharma Ltd
0 catalysts
Phase 2
epetraborole
epetraborole [INN]
Mycobacterium avium Infections
$ANTXAN2 Therapeutics, Inc.
0 catalysts
Phase 2
epsametostat
epsametostat [INN]
Peripheral T-Cell Lymphomas (PTCL)
Shanghai Haihe Biopharma Co Ltd
0 catalysts
Phase 2
esonadogene imvoparvovec
esonadogene imvoparvovec [INN]
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy)
Wuhan Neurophth Biological Technology Ltd
0 catalysts
Phase 2
estriol
Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy)
Estrogen receptor
VaRi Bioscience GmbH
0 catalysts
Phase 2
etigilimab
Adenocarcinoma Of The Gastroesophageal Junction
T-cell immunoreceptor with Ig and ITIM domains
$MREOMereo BioPharma Group plc
0 catalysts
Phase 2
etivelcabtagene erigedleucel
Follicular Lymphoma
Cellectis SA
0 catalysts
Phase 2
evalstotug
evalstotug [INN]
Melanoma
$BCABBioAtla, Inc.
0 catalysts
Phase 2
evarucabgene autoleucel
Refractory Multiple Myeloma
Nexcella Inc
0 catalysts
Phase 2
exaluren
exaluren [INN]
Alport Syndrome
$ELOXEloxx Pharmaceuticals, Inc.
0 catalysts